USFDA classifies inspection of Lupin#39;s Tarapur facility as #39;Official Action Indicated#39;

USFDA classifies inspection of Lupin#39;s Tarapur facility as #39;Official Action Indicated#39; "The company has received a communication from the US FDA classifying the inspection conducted at its Tarapur manufacturing (API) facility between September 16 to September 20, 2019 as Official Action Indicated (OAI)," Lupin Ltd said in a filing to BSE.

No comments:

Post a Comment